Abraham, G., Paing, W. W., Kaminski, J.et al. (2003) Effects of elevated serum prolactin on bone mineral density and bone metabolism in female patients with schizophrenia: a prospective study. Am. J. Psychiatry 160, 1618–1620.CrossRefGoogle Scholar

Adams, P. F., Marano, M. A. (1995) Current estimates for the National Health Interview Survey, 1994. Vital Health Stat. 10, 1–260.Google Scholar

Aizenberg, D., Zemishlany, Z., Dorfman-Etrog, P., Weizman, A. (1995) Sexual dysfunction in male schizophrenic patients. J. Clin. Psychiatry 56, 137–141.Google Scholar

Aleman, A., Kahn, R. S., Selten, J. P. (2003) Sex differences in the risk of schizophrenia: evidence from meta-analysis. Arch. Gen. Psychiatry 60, 565–571.CrossRefGoogle Scholar

Allebeck, P. (1989) Schizophrenia: a life-shortening disease. Schizophr. Bull. 15, 81–89.CrossRefGoogle Scholar

Allebeck, P., Rodvall, Y., Wistedt, B. (1985) Incidence of rheumatoid arthritis among patients with schizophrenia, affective psychosis and neurosis. Acta Psychiatr. Scand. 71, 615–619.CrossRefGoogle Scholar

Allison, D. B., Fontaine, K. R., Heo, M.et al. (1999a) The distribution of body mass index among individuals with and without schizophrenia. J. Clin. Psychiatry 60, 215–220.Google Scholar

Allison, D. B., Mentore, J. L., Heo, M.et al. (1999b) Antipsychotic-induced weight gain: a comprehensive research synthesis. Am. J. Psychiatry 156, 1686–1696.Google Scholar

Alvarez, L. M., Castillo, S. T., Perez Zuno, J. A.et al. (1995) [Activity of aryl sulfatase A enzyme in patients with schizophrenic disorders]. Rev. Invest. Clin. 47, 387–392.Google Scholar

American Diabetes Association (2006) Clinical practice recommendations. Diabetes Care29. Available online at http://care.diabetesjournals.org/content/vol29/suppl_1/.

American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity (2004) Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 27, 596–601.

Apostolakis, M., Kapetanakis, S. (1972) Plasma prolactin activity in patients with galactorrhea after treatment with psychotropic drugs. In Lactogenic Hormones, ed. Wolstenholme, G. E. W. and Knight, J.. Baltimore, MD: Williams and Wilkins, pp. 349–359.

Arce, C. R., Baca-Garcia, E., Diaz-Sastre, C., Baca, B. E. (1999) [Analytical thyroid disturbances in psychiatric inpatients.]Actas Esp. Psiquiatr. 27, 35–42.Google Scholar

Ataya, K., Mercado, A., Kartaginer, J., Abbasi, A., Moghissi, K. S. (1988) Bone density and reproductive hormones in patients with neuroleptic-induced hyperprolactinemia. Fertil. Steril. 50, 876–881.CrossRefGoogle Scholar

Atkinson, S. A., Ward, W. E. (2001) Clinical nutrition: 2. The role of nutrition in the prevention and treatment of adult osteoporosis. Can. Med. Assoc. J. 165, 1511–1514.Google Scholar

Ayuso-Mateos, J. L., Montanes, F., Lastra, I., Picazo, d.l.G., Ayuso-Gutierrez, J. L. (1997) human immunodeficiency virus infection in psychiatric patients: an unlinked anonymous study. Br. J. Psychiatry 170, 181–185.CrossRefGoogle Scholar

Baastrup, P. C., Christiansen, C., Transbol, I. (1980) Calcium metabolism in schizophrenic patients on long-term neuroleptic therapy. Neuropsychobiology 6, 56–59.CrossRefGoogle Scholar

Bagedahl-Strindlund, M. (1986) Mentally ill mothers and their children: an epidemiological study of antenatal care consumption, obstetric conditions, and neonatal health. Acta Psychiatr. Scand. 74, 32–40.CrossRefGoogle Scholar

Baillargeon, J., Ducate, S., Pulvino, J.et al. (2003) The association of psychiatric disorders and human immunodeficiency virus infection in the correctional setting. Ann. Epidemiol. 13, 606–612.CrossRefGoogle Scholar

Baldwin, J. A. (1979) Schizophrenia and physical disease. Psychol. Med. 9, 611–618.CrossRefGoogle Scholar

Ballenger, J. C., Post, R. M., Sternberg, D. E.et al. (1979) Headaches after lumbar puncture and insensitivity to pain in psychiatric patients. N. Engl. J. Med. 301, 110.Google Scholar

Ban, T. A., Guy, W., Wilson, W. H. (1985) Neuroleptic-induced skin pigmentation in chronic hospitalized schizophrenic patients. Can. J. Psychiatry 30, 406–408.CrossRefGoogle Scholar

Barak, Y., Achiron, A., Mandel, M., Mirecki, I., Aizenberg, D. (2005) Reduced cancer incidence among patients with schizophrenia. Cancer 104, 2817–2821.CrossRefGoogle Scholar

Basu, R., Brar, J. S., Chengappa, K. N.et al. (2004) The prevalence of the metabolic syndrome in patients with schizoaffective disorder–bipolar subtype. Bipolar Disord. 6, 314–318.CrossRefGoogle Scholar

Baxter, D., Appleby, L. (1999) Case register study of suicide risk in mental disorders. Br. J. Psychiatry 175, 322–326.CrossRefGoogle Scholar

Beaumont, J. G., Dimond, S. J. (1973) Brain disconnection and schizophrenia. Br. J. Psychiatry 123, 661–662.CrossRefGoogle Scholar

Benca, R. M., Obermeyer, W. H., Thisted, R. A., Gillin, J. C. (1992) Sleep and psychiatric disorders: a meta-analysis. Arch. Gen. Psychiatry 49, 651–668.CrossRefGoogle Scholar

Bennedsen, B. E. (1998) Adverse pregnancy outcome in schizophrenic women: occurrence and risk factors. Schizophr. Res. 33, 1–26.CrossRefGoogle Scholar

Bennedsen, B. E., Mortensen, P. B., Olesen, A. V., Henriksen, T. B. (1999) Preterm birth and intra-uterine growth retardation among children of women with schizophrenia. Br. J. Psychiatry 175, 239–245.CrossRefGoogle Scholar

Bennedsen, B. E., Mortensen, P. B., Olesen, A. V., Henriksen, T. B. (2001a) Congenital malformations, stillbirths, and infant deaths among children of women with schizophrenia. Arch. Gen. Psychiatry 58, 674–679.Google Scholar

Bennedsen, B. E., Mortensen, P. B., Olesen, A. V., Henriksen, T. B., Frydenberg, M. (2001b) Obstetric complications in women with schizophrenia. Schizophr. Res. 47, 167–175.Google Scholar

Bennett, N., Dodd, T., Flatley, J., Freeth, S., Bolling, K. (1995) Health Survey for England 1993. London: HMSO.

Bergemann, N., Auler, B., Parzer, P.et al. (2001) High bone turnover but normal bone mineral density in women with schizophrenia. Bone 28, 248.Google Scholar

Bernstein, L., Ross, R. K. (1993) Endogenous hormones and breast cancer risk. Epidemiol. Rev. 15, 48–65.CrossRefGoogle Scholar

Bernstein, L., Ross, R. K., Pike, M. C., Brown, J. B., Henderson, B. E. (1990) Hormone levels in older women: a study of post-menopausal breast cancer patients and healthy population controls. Br. J. Cancer 61, 298–302.CrossRefGoogle Scholar

Bilici, M., Cakirbay, H., Guler, M.et al. (2002) Classical and atypical neuroleptics, and bone mineral density, in patients with schizophrenia. Int. J. Neurosci. 112, 817–828.CrossRefGoogle Scholar

Bishop, J. R., Alexander, B., Lund, B. C., Klepser, T. B. (2004) Osteoporosis screening and treatment in women with schizophrenia: a controlled study. Pharmacotherapy 24, 515–521.CrossRefGoogle Scholar

Black, D. W., Winokur, G., Warrack, G. (1985) Suicide in schizophrenia: the Iowa Record Linkage Study. J. Clin. Psychiatry 46, 14–17.Google Scholar

Blackburn, H., Keys, A., Simonson, E., Rautaharju, P., Punsar, S. (1960) Electrocardiogram in population studies. Circulation 21, 1160–1175.CrossRefGoogle Scholar

Blank, M. B., Mandell, D. S., Aiken, L., Hadley, T. R. (2002) Co-occurrence of human immunodeficiency virus and serious mental illness among Medicaid recipients. Psychiatr. Serv. 53, 868–873.CrossRefGoogle Scholar

Bleuler, E. (1911) Textbook of Psychiatry. New York: Dover Publications.

Blohmke, M., Koschorrek, B., Stelzer, O. (1970) Häufigkeiten von Risikofaktoren der koronaren Herzkrankheiten in verschiedenen Altersgruppen und sozialen Schichten bei Männern. Z. Geront. 3, 201.Google Scholar

Blum, A., Tempey, F. W., Lynch, W. J. (1983) Somatic findings in patients with psychogenic polydipsia. J. Clin. Psychiatry 44, 55–56.Google Scholar

Blumensohn, R., Ringler, D., Eli, I. (2002) Pain perception in patients with schizophrenia. J. Nerv. Ment. Dis. 190, 481–483.CrossRefGoogle Scholar

Bonney, W. W., Gupta, S., Hunter, D. R., Arndt, S. (1997) Bladder dysfunction in schizophrenia. Schizophr. Res. 25, 243–249.CrossRefGoogle Scholar

Bowie, C. R., Harvey, P. D. (2005) Cognition in schizophrenia: impairments, determinants, and functional importance. Psychiatr. Clin. North Am. 28, 613–633, 626.CrossRefGoogle Scholar

Bracken, P., Coll, P. (1985) Homocystinuria and schizophrenia: literature review and case report. J. Nerv. Ment. Dis. 173, 51–55.CrossRefGoogle Scholar

Bremner, A. J., Regan, A. (1991) Intoxicated by water: polydipsia and water intoxication in a mental handicap hospital. Br. J. Psychiatry 158, 244–250.CrossRefGoogle Scholar

Brookes, G., Ahmed, A. G. (2002) Pharmacological treatments for psychosis-related polydipsia. Cochrane Database Syst. Rev. CD003544.CrossRef

Brown, J. S. Jr. (1996) Geographic correlation of multiple sclerosis with tick-borne diseases. Mult. Scler. 1, 257–261.CrossRefGoogle Scholar

Brown, S. (1997) Excess mortality of schizophrenia: a meta-analysis. Br. J. Psychiatry 171, 502–508.CrossRefGoogle Scholar

Brown, S., Birtwistle, J., Roe, L., Thompson, C. (1999) The unhealthy lifestyle of people with schizophrenia. Psychol. Med. 29, 697–701.CrossRefGoogle Scholar

Brown, S., Inskip, H., Barraclough, B. (2000) Causes of the excess mortality of schizophrenia. Br. J. Psychiatry 177, 212–217.CrossRefGoogle Scholar

Bundesgesundheitsministerium der BRD (1991) Daten des Gesundheitswesens. Baden-Baden: Nomos.

Burkitt, E. A., Khan, K. (1973) Myasthenia gravis and schizophrenia: a rare combination. Br. J. Psychiatry 122, 735–736.CrossRefGoogle Scholar

Bushe, C., Holt, R. (2004) Prevalence of diabetes and impaired glucose tolerance in patients with schizophrenia. Br. J. Psychiatry (Suppl.) 47, S67–S71.CrossRefGoogle Scholar

Cadalbert, M., Fenner, A., Schamaun, M. (1970) [Functional megacolon in mental patients.]Helv. Chir. Acta 37, 181–184.Google Scholar

Campbell, E. B., Foley, S. (2004) Coeliac disease and schizophrenia: data do not support hypothesis. Br. Med. J. 328, 1017.Google Scholar

Canuso, C. M., Goldstein, J. M., Wojcik, J.et al. (2002) Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder. Psychiatr. Res. 111, 11–20.CrossRefGoogle Scholar

Casadebaig, F., Philippe, A., Guillaud-Bataille, J. M.et al. (1997) Schizophrenic patients: physical health and access to somatic care. Eur. Psychiatry 12, 289–293.CrossRefGoogle Scholar

Casey, D. E. (1993) Neuroleptic-induced acute extrapyramidal syndromes and tardive dystinesia. Psychiatr. Clin. North Am. 16, 589–610.CrossRefGoogle Scholar

Chafetz, L., White, M. C., Collins-Bride, G., Nickens, J. (2005) The poor general health of the severely mentally ill: impact of schizophrenic diagnosis. Commun. Ment. Health J. 41, 169–184.CrossRefGoogle Scholar

Chaudhury, S., Chandra, S., Augustine, M. (1994) Prevalence of Australia-antigen (Hbsag) in institutionalized patients with psychosis. Br. J. Psychiatry 164, 542–543.CrossRefGoogle Scholar

Chen, C. H. (1994) Seroprevalence of human immunodeficiency virus infection among Chinese psychiatric patients in Taiwan. Acta Psychiatr. Scand. 89, 441–442.CrossRefGoogle Scholar

Cheng, H. S., Wang, L. C. (2005) Intestinal parasites may not cause nosocomial infections in psychiatric hospitals. Parasitol. Res. 95, 358–362.CrossRefGoogle Scholar

Chong, S. A., Tan, L. L., Wong, M. C.et al. (1997) Disordered water homeostasis in Asian patients with schizophrenia. Aust. N. Z. J. Psychiatry 31, 869–873.CrossRefGoogle Scholar

Chong, S. A., Mythily, Lum A., Goh, H. Y., Chan, Y. H. (2003) Prolonged QTc intervals in medicated patients with schizophrenia. Hum. Psychopharmacol. 18, 647–649.CrossRefGoogle Scholar

Chopra, I. J., Solomon, D. H., Huang, T. S. (1990) Serum thyrotropin in hospitalized psychiatric patients: evidence for hyperthyrotropinemia as measured by an ultrasensitive thyrotropin assay. Metabolism 39, 538–543.CrossRefGoogle Scholar

Cividini, A., Pistorio, A., Regazzetti, A.et al. (1997) Hepatitis C virus infection among institutionalized psychiatric patients: a regression analysis of indicators of risk. J. Hepatol. 27, 455–463.CrossRefGoogle Scholar

Clarke, D. J., Buckley, M. E. (1989) Familial association of albinism and schizophrenia. Br. J. Psychiatry 155, 551–553.CrossRefGoogle Scholar

Clevenger, C. V., Furth, P. A., Hankinson, S. E., Schuler, L. A. (2003) The role of prolactin in mammary carcinoma. Endocr. Rev. 24, 1–27.CrossRefGoogle Scholar

Cnattingius, S., Mills, J. L., Yuen, J., Eriksson, O., Salonen, H. (1997) The paradoxical effect of smoking in preeclamptic pregnancies: smoking reduces the incidence but increases the rates of perinatal mortality, abruptio placentae, and intrauterine growth restriction. Am. J. Obstet. Gynecol. 177, 156–161.CrossRefGoogle Scholar

Coghlan, R., Lawrence, D., Holman, D'A., Jablensky, A. (2001) Duty to Care: Physical Illness in People with Mental Illness. Perth, WA: University of Western Australia, Department of Public Health, Department of Psychiatry and Behavioural Science. Available online at www.populationhealth.uwa.edu.au/dutytocare

Cohen, A. J., Roe, F. J. (2000) Review of risk factors for osteoporosis with particular reference to a possible aetiological role of dietary salt. Food Chem. Toxicol. 38, 237–253.CrossRefGoogle Scholar

Cohen, D., Gispen-de Wied, C. C. (2003) [Schizophrenia and diabetes mellitus: not an improbable combination.]Ned. Tijdschr. Geneeskd. 147, 993–996.Google Scholar

Cohen, H., Loewenthal, U., Matar, M., Kotler, M. (2001) [Heart rate variability in schizophrenic patients treated with antipsychotic agents.]Harefuah 140, 1142–7, 1231.Google Scholar

Cohen, K. L., Swigar, M. E. (1979) Thyroid function screening in psychiatric patients. J. Am. Med. Ass. 242, 254–257.CrossRefGoogle Scholar

Cohen, M., Dembling, B., Schorling, J. (2002) The association between schizophrenia and cancer: a population-based mortality study. Schizophr. Res. 57, 139–146.CrossRefGoogle Scholar

Cohler, B. J., Gallant, D. H., Grunebaum, H. U., Weiss, J. L., Gamer, E. (1975) Pregnancy and birth complications among mentally ill and well mothers and their children. Soc. Biol. 22, 269–278.CrossRefGoogle Scholar

Cohn, T., Prud'homme, D., Streiner, D., Kameh, H., Remington, G. (2004) Characterizing coronary heart disease risk in chronic schizophrenia: high prevalence of the metabolic syndrome. Can. J. Psychiatry 49, 753–760.CrossRefGoogle Scholar

Colton, C. W., Manderscheid, R. W. (2006) Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev. Chronic Dis. 3, A42.Google Scholar

Conejero-Goldberg, C., Torrey, E. F., Yolken, R. H. (2003) Herpesviruses and Toxoplasma gondii in orbital frontal cortex of psychiatric patients. Schizophr. Res. 60, 65–69.CrossRefGoogle Scholar

Coodin, S. (2001) Body mass index in persons with schizophrenia. Can. J. Psychiatry 46, 549–555.CrossRefGoogle Scholar

Cooper, A. F. (1976) Deafness and psychiatric illness. Br. J. Psychiatry 129, 216–226.CrossRefGoogle Scholar

Correll, C. U., Leucht, S., Kane, J. M. (2004) Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. Am. J. Psychiatry 161, 414–425.CrossRefGoogle Scholar

Cotran, R. S., Kumar, V., Robbins, S. L. (1989) Robbins Pathologic Basis of Disease, 4th edn. Philadelphia, PA: W.B. Saunders.

Council of the National Osteoporosis Foundation (1996) Guidelines for the early detection of osteoporosis and prediction of fracture risk. S. Afr. Med. J. 86, 1113–1116.

Cournos, F., McKinnon, K. (1997) human immunodeficiency virus seroprevalence among people with severe mental illness in the United States: a critical review. Clin. Psychol. Rev. 17, 259–269.CrossRefGoogle Scholar

Cournos, F., Empfield, M., Horwath, E.et al. (1991) human immunodeficiency virus seroprevalence among patients admitted to two psychiatric hospitals. Am. J. Psychiatry 148, 1225–1230.Google Scholar

Cournos, F., Horwath, E., Guido, J. R., McKinnon, K., Hopkins, N. (1994) human immunodeficiency virus-1 infection at two public psychiatric hospitals in New York City. acquired immundeficiency syndrome Care 6, 443–452.Google Scholar

Cradock-O'Leary, J., Young, A. S., Yano, E. M., Wang, M. M., Lee, M. L. (2002) Use of general medical services by ventricular arrhythmia patients with psychiatric disorders. Psychiatr. Serv. 53, 874–878.CrossRefGoogle Scholar

Cramer, J. A., Rosenheck, R. (1998) Compliance with medication regimens for mental and physical disorders. Psychiatr. Serv. 49, 196–201.CrossRefGoogle Scholar

Creese, I., Feinberg, A. P., Snyder, S. H. (1976) Butyrophenone influences on the opiate receptor. Eur. J. Pharmacol. 36, 231–235.CrossRefGoogle Scholar

Curkendall, S. M., Mo, J., Glasser, D. B., Rose, S. M., Jones, J. K. (2004) Cardiovascular disease in patients with schizophrenia in Saskatchewan, Canada. J. Clin. Psychiatry 65, 715–720.CrossRefGoogle Scholar

Dalton, S. O., Munk, L. T., Mellemkjaer, L., Johansen, C., Mortensen, P. B. (2003) Schizophrenia and the risk for breast cancer. Schizophr. Res. 62, 89–92.CrossRefGoogle Scholar

Dalton, S. O., Laursen, T. M., Mellemkjaer, L., Johansen, C., Mortensen, P. B. (2004) Risk for cancer in parents of patients with schizophrenia. Am. J. Psychiatry 161, 903–908.CrossRefGoogle Scholar

Dalton, S. O., Mellemkjaer, L., Thomassen, L., Mortensen, P. B., Johansen, C. (2005) Risk for cancer in a cohort of patients hospitalized for schizophrenia in Denmark, 1969–1993. Schizophr. Res. 75, 315–324.CrossRefGoogle Scholar

Dasananjali, T. (1994) The prevalence of human immunodeficiency virus infection among mentally ill offenders in Thailand. J. Med. Assoc. Thai. 77, 257–260.Google Scholar

Daumit, G. L., Goldberg, R. W., Anthony, C.et al. (2005) Physical activity patterns in adults with severe mental illness. J. Nerv. Ment. Dis. 193, 641–646.CrossRefGoogle Scholar

Daumit, G. L., Pronovost, P. J., Anthony, C. B.et al. (2006) Adverse events during medical and surgical hospitalizations for persons with schizophrenia. Arch. Gen. Psychiatry 63, 267–272.CrossRefGoogle Scholar

David, A., Malmberg, A., Lewis, G., Brandt, L., Allebeck, P. (1995) Are there neurological and sensory risk factors for schizophrenia?Schizophr. Res. 14, 247–251.Google Scholar

Davidson, M. (2002) Risk of cardiovascular disease and sudden death in schizophrenia. J. Clin. Psychiatry 63 (Suppl. 9), 5–11.Google Scholar

Davidson, S., Judd, F., Jolley, D.et al. (2001) Cardiovascular risk factors for people with mental illness. Aust. N. Z. J. Psychiatry 35, 196–202.CrossRefGoogle Scholar

Davis, G. C., Buchsbaum, M. S., Naber, D.et al. (1982) Altered pain perception and cerebrospinal endorphins in psychiatric illness. Ann. N. Y. Acad. Sci. 398, 366–373.CrossRefGoogle Scholar

Davis, J. M., Cole, J. O. (1975) Antipsychotic drugs. In American Handbook of Psychiatry, ed. Arieti, S.. New York: Basic Books, pp. 441–475.

Hert, M. A., Winkel, R., Eyck, D.et al. (2006) Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication. Schizophr. Res. 83, 87–93.CrossRefGoogle Scholar

Leon, J. (2003) Polydipsia: a study in a long-term psychiatric unit. Eur. Arch. Psychiatr Clin. Neurosci. 253, 37–39.CrossRefGoogle Scholar

Leon, J., Diaz, F. J. (2005) A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr. Res. 76, 135–157.CrossRefGoogle Scholar

Leon, J., Verghese, C., Tracy, J. I., Josiassen, R. C., Simpson, G. M. (1994) Polydipsia and water intoxication in psychiatric patients: a review of the epidemiological literature. Biol. Psychiatry 35, 408–419.CrossRefGoogle Scholar

Leon, J., Dadvand, M., Canuso, C.et al. (1996) Polydipsia and water intoxication in a long-term psychiatric hospital. Biol. Psychiatry 40, 28–34.CrossRefGoogle Scholar

Leon, J., Tracy, J., McCann, E., McGrory, A. (2002) Polydipsia and schizophrenia in a psychiatric hospital: a replication study. Schizophr. Res. 57, 293–301.CrossRefGoogle Scholar

Santis, A., Addolorato, G., Romito, A.et al. (1997) Schizophrenic symptoms and SPECT abnormalities in a coeliac patient: regression after a gluten-free diet. J. Intern. Med. 242, 421–423.CrossRefGoogle Scholar

Delaplaine, R., Ifabumuyi, O. I., Merskey, H., Zarfas, J. (1978) Significance of pain in psychiatric hospital patients. Pain 4, 361–366.Google Scholar

Delisi, L. E., Smith, S. B., Hamovit, J. R.et al. (1986) Herpes simplex virus, cytomegalovirus and Epstein–Barr virus antibody titres in sera from schizophrenic patients. Psychol. Med. 16, 757–763.CrossRefGoogle Scholar

Delva, N. J., Crammer, J. L., Jarzylo, S. V.et al. (1989) Osteopenia, pathological fractures, and increased urinary calcium excretion in schizophrenic patients with polydipsia. Biol. Psychiatry 26, 781–793.CrossRefGoogle Scholar

Desai, M. M., Rosenheck, R. A., Druss, B. G., Perlin, J. B. (2002) Mental disorders and quality of diabetes care in the veterans health administration. American Journal of Psychiatry 159, 1584–1590.CrossRefGoogle Scholar

Destounis, N. (1966) The relationship between schizophrenia and toxoplasmosis: a critical study. Del. Med. J. 38, 349–351.Google Scholar

Dewan, M. J., Bick, P. A. (1985) Normal pressure hydrocephalus and psychiatric patients. Biol. Psychiatry 20, 1127–1131.CrossRefGoogle Scholar

Dickerson, F. B., Brown, C. H., Kreyenbuhl, J.et al. (2004) Sexual and reproductive behaviors among persons with mental illness. Psychiatr. Serv. 55, 1299–1301.CrossRefGoogle Scholar

Dickerson, F. B., Brown, C. H., Daumit, G. L.et al. (2006) Health status of individuals with serious mental illness. Schizophr. Bull. 32, 584–589.Google Scholar

Dickerson, J. W., Wiryanti, J. (1978) Pellagra and mental disturbance. Proc. Nutr. Soc. 37, 167–171.CrossRefGoogle Scholar

Dickson, R. A., Glazer, W. M. (1999) Neuroleptic-induced hyperprolactinemia. Schizophr. Res. 35 (Suppl.), S75–S86.CrossRefGoogle Scholar

Dixon, L., Haas, G., Weiden, P. J., Sweeney, J., Frances, A. J. (1991) Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am. J. Psychiatry 148, 224–230.Google Scholar

Dixon, L., Postrado, L., Delahanty, J., Fischer, P. J., Lehman, A. (1999) The association of medical comorbidity in schizophrenia with poor physical and mental health. J. Nerv. Ment. Dis. 187, 496–502.CrossRefGoogle Scholar

Dixon, L., Weiden, P., Delahanty, J.et al. (2003) Prevalence and correlates of diabetes in national schizophrenia samples. Schizophr. Bull. 26, 903–912.Google Scholar

Dohan, F. C., Grasberger, J. C. (1973) Relapsed schizophrenics: earlier discharge from the hospital after cereal-free, milk-free diet. Am. J. Psychiatry 130, 685–688.CrossRefGoogle Scholar

Dohan, F. C., Grasberger, J. C., Lowell, F. M., Johnston, H. T.., Arbegast, A. W. (1969) Relapsed schizophrenics: more rapid improvement on a milk- and cereal-free diet. Br. J. Psychiatry 115, 595–596.CrossRefGoogle Scholar

Dorrell, W. (1973) Myasthenia gravis and schizophrenia. Br. J. Psychiatry 123, 249.CrossRefGoogle Scholar

Drake, R. E., Wallach, M. A. (1989) Substance abuse among the chronic mentally ill. Hosp. Commun. Psychiatry 40, 1041–1046.CrossRefGoogle Scholar

Drake, R. E., Rosenberg, S. D., Mueser, K. T. (1996) Assessing substance use disorder in persons with severe mental illness. New Dir. Ment. Health Serv.70, 3–17.CrossRefGoogle Scholar

Drossman, D. A. (1994) Irritable bowel syndrome. Gastroenterologist 2, 315–326.Google Scholar

Duc, L. (1952) [Contribution to the study of the disorders of carbohydrate metabolism in mental disorders: diabetes and psychoses.]Schweiz. Arch. Neurol. Psychiatr. 69, 89–169.Google Scholar

du Pan, R. M., Muller, C. (1977) [Cancer mortality in patients of psychiatric hospitals.]Schweiz. Med. Wochenschr. 107, 597–604.Google Scholar

Dupont, A., Jensen, O. M., Strömgren, E., Jablensky, A. (1986) Incidence of cancer in patients diagnosed as schizophrenic in Denmark. In Psychiatric Case Registers in Public Health, eds. Horn, G. H. Ten, Giel, R., Gulbinat, W. H.. Amsterdam: Elsevier, pp. 229–239.

Dworkin, R. H. (1994) Pain insensitivity in schizophrenia: a neglected phenomenon and some implications. Schizophr. Bull. 20, 235–248.CrossRefGoogle Scholar

Eaton, W. W., Hayward, C., Ram, R. (1992) Schizophrenia and rheumatoid arthritis: a review. Schizophr. Res. 6, 181–192.CrossRefGoogle Scholar

Eaton, W. W., Mortensen, P. B., Agerbo, E.et al. (2004) Coeliac disease and schizophrenia: population-based case control study with linkage of Danish national registers. Br. Med. J. 328, 438–439.CrossRefGoogle Scholar

Eaton, W. W., Byrne, M., Ewald, H.et al. (2006) Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am. J. Psychiatry 163, 521–528.CrossRefGoogle Scholar

Ebert, T., Kotler, M. (2005) Prenatal exposure to influenza and the risk of subsequent development of schizophrenia. Isr. Med. Assoc. J. 7, 35–38.Google Scholar

Ehrentheil, O. F. (1957) Common medical disorders rarely found in psychotic patients. Am. Med. Assoc. Arch. Neurol. Psychiatry 77, 178–186.CrossRefGoogle Scholar

Empfield, M., Cournos, F., Meyer, I.et al. (1993) human immunodeficiency virus seroprevalence among homeless patients admitted to a psychiatric inpatient unit. Am. J. Psychiatry 150, 47–52.Google Scholar

Emsley, R. A., Meer, M. H., Aalbers, C., Taljaard, J. J. (1990) Inappropriate antidiuretic state in long-term psychiatric inpatients. S. Afr. Med. J. 77, 307–308.Google Scholar

Enger, C., Weatherby, L., Reynolds, R. F., Glasser, D. B., Walker, A. M. (2004) Serious cardiovascular events and mortality among patients with schizophrenia. J. Nerv. Ment. Dis. 192, 19–27.CrossRefGoogle Scholar

Erlenmeyer-Kimling, L. (1968) Mortality rates in the offspring of schizophrenic parents and a physiological advantage hypothesis. Nature 220, 798–800.CrossRefGoogle Scholar

Essen-Moller, W. (1935) Untersuchungen über die Fruchtbarkeit gewisser Gruppen von Geisteskranken. Acta Psychiatr. Neurol. (Suppl.) 8, 1–314.Google Scholar

Evenson, R. C., Jos, C. J., Mallya, A. R. (1987) Prevalence of polydipsia among public psychiatric patients. Psychol. Rep. 60, 803–807.CrossRefGoogle Scholar

Ewald, H., Mortensen, P. B., Mors, O. (2001) Decreased risk of acute appendicitis in patients with schizophrenia or manic-depressive psychosis. Schizophr. Res. 49, 287–293.CrossRefGoogle Scholar

Expert Group: Schizophrenia and Diabetes 2003 (2004) Expert Consensus Meeting, Dublin, 3–4 October 2003: consensus summary. Br. J. Psychiatry (Suppl.) 47, S112-S114.

Fellerhoff, B., Laumbacher, B., Wank, R. (2005) High risk of schizophrenia and other mental disorders associated with chlamydial infections: hypothesis to combine drug treatment and adoptive immunotherapy. Med. Hypotheses 65, 243–252.CrossRefGoogle Scholar

Fenton, W. S. (2000) Prevalence of spontaneous dyskinesia in schizophrenia. J. Clin. Psychiatry 61, 10–14.Google Scholar

Ferrier, I. N. (1985) Water intoxication in patients with psychiatric illness. Br. Med. J. (Clin. Res. Edn) 291, 1594–1596.CrossRefGoogle Scholar

Filik, R., Sipos, A., Kehoe, P. G.et al. (2006) The cardiovascular and respiratory health of people with schizophrenia. Acta Psychiatr. Scand. 113, 298–305.CrossRefGoogle Scholar

Fisher, I. I., Bienskii, A. V., Fedorova, I. V. (1996) Experience in using serological tests in detecting tuberculosis in patients with severe mental pathology. Probl. Tuberk. 1, 19–20.Google Scholar

Folsom, D. P., McCahill, M., Bartels, S.et al. (2002) Medical comorbidity and receipt of medical care by older homeless people with schizophrenia or depression. Psychiatri. Serv. 53, 1456–1460.CrossRefGoogle Scholar

Fox, B. H., Howell, M. A. (1974) Cancer risk among psychiatric patients: a hypothesis. Int. J. Epidemiol. 3, 207–208.CrossRefGoogle Scholar

Freedman, R. (2003) Schizophrenia. N. Engl. J. Med. 349, 1738–1749.CrossRefGoogle Scholar

Friedlander, A. H., Marder, S. R. (2002) The psychopathology, medical management and dental implications of schizophrenia. J. Am. Dent. Assoc. 133, 603–610.CrossRefGoogle Scholar

Galbraith, D. A., Gordon, B. A., Feleki, V., Gordon, N., Cooper, A. J. (1989) Metachromatic leukodystrophy (metachromatic leukodystrophy) in hospitalized adult schizophrenic patients resistant to drug treatment. Can. J. Psychiatry 34, 299–302.CrossRefGoogle Scholar

Gallien, M., Schnetzler, J. P., Morin, J. (1975) [Antinuclear antibodies and lupus due to phenothiazines in 600 hospitalized patients.]Ann. Med. Psychol. (Paris) 1, 237–248.Google Scholar

Geschwind, N. (1977) Insensitivity to pain in psychotic patients. N. Engl. J. Med. 296, 1480.Google Scholar

Ghadirian, A. M., Chouinard, G., Annable, L. (1982) Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients. J. Nerv. Ment. Dis. 170, 463–467.CrossRefGoogle Scholar

Gingell, K. H., Darley, J. S., Lengua, C. A., Baddela, P. (1993) Menstrual changes with antipsychotic drugs. Br. J. Psychiatry 162, 127.CrossRefGoogle Scholar

Gittleson, N. L., Richardson, T. D. (1973) Myasthenia gravis and schizophrenia: a rare combination. Br. J. Psychiatry 122, 343–344.CrossRefGoogle Scholar

Goff, D. C., Sullivan, L. M., McEvoy, J. P.et al. (2005) A comparison of ten-year cardiac risk estimates in schizophrenia patients from the Clinical Trials of Antipsychotic Treatment Effectiveness study and matched controls. Schizophr. Res. 80, 45–53.CrossRefGoogle Scholar

Goffin, V., Touraine, P., Pichard, C., Bernichtein, S., Kelly, P. A. (1999) Should prolactin be reconsidered as a therapeutic target in human breast cancer?Mol. Cell. Endocrinol. 151, 79–87.CrossRefGoogle Scholar

Goldacre, M. J., Kurina, L. M., Yeates, D., Seagroat, V., Gill, L. (2000) Use of large medical databases to study associations between diseases. Q. J. Med. 93, 669–675.CrossRefGoogle Scholar

Goldacre, M. J., Kurina, L. M., Wotton, C. J., Yeates, D., Seagroat, V. (2005) Schizophrenia and cancer: an epidemiological study. Br. J. Psychiatry 187, 334–338.CrossRefGoogle Scholar

Goldfarb, W. (1958) Pain reactions in a group of institutionalized schizophrenic children. Am. J. Orthopsychiatry 28, 777–785.CrossRefGoogle Scholar

Goldman, L. S. (1999) Medical illness in patients with schizophrenia. J. Clin. Psychiatry 60 (Suppl. 21), 10–15.Google Scholar

Goodman, S. H., Emory, E. K. (1992) Perinatal complications in births to low socioeconomic status schizophrenic and depressed women. J. Abnorm. Psychol. 101, 225–229.CrossRefGoogle Scholar

Gottesman, I. I., Groome, C. S. (1997) human immunodeficiency virus/acquired immundeficiency syndrome risks as a consequence of schizophrenia. Schizophr. Bull. 23, 675–684.CrossRefGoogle Scholar

Gourdy, P., Ruidavets, J. B., Ferrieres, J.et al. (2001) Prevalence of type 2 diabetes and impaired fasting glucose in the middle-aged population of three French regions: the MONICA study 1995–97. Diabetes Metab. 27, 347–358.Google Scholar

Grady, D., Rubin, S. M., Petitti, D. B.et al. (1992) Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann. Intern. Med. 117, 1016–1037.CrossRefGoogle Scholar

Grassi, L. (1996) Risk of human immunodeficiency virus infection in psychiatrically ill patients. acquired immundeficiency syndrome Care 8, 103–116.Google Scholar

Gregg, D. (1939) The paucity of arthritis among psychotic cases. Am. J. Psychiatry 95, 853–858.CrossRefGoogle Scholar

Grinshpoon, A., Barchana, M., Ponizovsky, A.et al. (2005) Cancer in schizophrenia: is the risk higher or lower?Schizophr. Res. 73, 333–341.Google Scholar

Gulbinat, W., Dupont, A., Jablensky, A.et al. (1992) Cancer incidence of schizophrenic patients: results of record linkage studies in three countries. Br. J. Psychiatry (Suppl.) 18, 75–83.Google Scholar

Gupta, S., Masand, P. S., Kaplan, D., Bhandary, A., Hendricks, S. (1997) The relationship between schizophrenia and irritable bowel syndrome (irritable bowel syndrome). Schizophr. Res. 23, 265–268.CrossRefGoogle Scholar

Hafner, H., Maurer, K., Loffler, W.et al. (1994) The epidemiology of early schizophrenia: influence of age and gender on onset and early course. Br. J. Psychiatry (Suppl.) 23, 29–38.Google Scholar

Halbreich, U., Palter, S. (1996) Accelerated osteoporosis in psychiatric patients: possible pathophysiological processes. Schizophr. Bull. 22, 447–454.CrossRefGoogle Scholar

Halbreich, U., Rojansky, N., Palter, S.et al. (1995) Decreased bone mineral density in medicated psychiatric patients. Psychosom. Med. 57, 485–491.CrossRefGoogle Scholar

Halbreich, U., Kinon, B. J., Gilmore, J. A., Kahn, L. S. (2003) Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects. Psychoneuroendocrinology 28 (Suppl. 1), 53–67.CrossRefGoogle Scholar

Halonen, P. E., Rimon, R., Arohonka, K., Jantti, V. (1974) Antibody levels to herpes simplex type I, measles and rubella viruses in psychiatric patients. Br. J. Psychiatry 125, 461–465.CrossRefGoogle Scholar

Harris, E. C., Barraclough, B. (1998) Excess mortality of mental disorder. Br. J. Psychiatry 173, 11–53.CrossRefGoogle Scholar

Harrison, G., Owens, D., Holton, A., Neilson, D., Boot, D. (1988) A prospective study of severe mental disorder in Afro-Caribbean patients. Psychol. Med. 18, 643–657.CrossRefGoogle Scholar

Harvey, I., Williams, M., McGuffin, P., Toone, B. K. (1990) The functional psychoses in Afro-Caribbeans. Br. J. Psychiatry 157, 515–522.CrossRefGoogle Scholar

Hatta, K., Takahashi, T., Nakamura, H.et al. (1998) Abnormal physiological conditions in acute schizophrenic patients on emergency admission: dehydration, hypokalemia, leukocytosis and elevated serum muscle enzymes. Eur. Arch. Psychiatr. Clin. Neurosci. 248, 180–188.CrossRefGoogle Scholar

Heiskanen, T., Niskanen, L., Lyytikainen, R., Saarinen, P. I., Hintikka, J. (2003) Metabolic syndrome in patients with schizophrenia. J. Clin. Psychiatry 64, 575–579.CrossRefGoogle Scholar

Hennessy, S., Bilker, W. B., Knauss, J. S.et al. (2002) Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data. Br. Med. J. 325, 1070.CrossRefGoogle Scholar

Herkert, E. E., Wald, A., Romero, O. (1972) Tuberous sclerosis and schizophrenia. Dis. Nerv. Syst. 33, 439–445.Google Scholar

Herold, G. (2002) Innere Medizin. Köln: Gerd Herold.

Hinterhuber, H., Lochenegg, L. (1975) [Gastric ulcers, stress and schizophrenia: incidence of gastric ulcers in male schizophrenic patients.]Arch. Psychiatr. Nervenkr. 220, 335–345.CrossRefGoogle Scholar

Hoffer, A. (1970) Pellagra and schizophrenia. Psychosomatics 11, 522–525.CrossRefGoogle Scholar

Holt, R. I., Peveler, R. C., Byrne, C. D. (2004) Schizophrenia, the metabolic syndrome and diabetes. Diabet. Med. 21, 515–523.CrossRefGoogle Scholar

Homel, P., Casey, D., Allison, D. B. (2002) Changes in body mass index for individuals with and without schizophrenia, 1987–1996. Schizophr. Res. 55, 277–284.CrossRefGoogle Scholar

Horrobin, D. F., Ally, A. I., Karmali, R. A.et al. (1978) Prostaglandins and schizophrenia: further discussion of the evidence. Psychol. Med. 8, 43–48.CrossRefGoogle Scholar

Hoskins, R. G., Sleeper, F. H. (1933) Organic functions in schizophrenia. Arch. Neurol. Psychiat. 30, 123–140.CrossRefGoogle Scholar

Howard, L., Shah, N., Salmon, M., Appleby, L. (2003) Predictors of social services supervision of babies of mothers with mental illness after admission to a psychiatric mother and baby unit. Soc. Psychiatry Psychiatr. Epidemiol. 38, 450–455.CrossRefGoogle Scholar

Howland, R. H. (1990) Schizophrenia and amyotrophic lateral sclerosis. Compr. Psychiatry 31, 327–336.CrossRefGoogle Scholar

Hsiao, C. C., Ree, S. C., Chiang, Y. L., Yeh, S. S., Chen, C. K. (2004) Obesity in schizophrenic outpatients receiving antipsychotics in Taiwan. Psychiatry Clin. Neurosci. 58, 403–409.CrossRefGoogle Scholar

Hummer, M., Malik, P., Gasser, R. W.et al. (2005) Osteoporosis in patients with schizophrenia. Am. J. Psychiatry 162, 162–167.CrossRefGoogle Scholar

Hung, C. F., Wu, C. K., Lin, P. Y. (2005) Diabetes mellitus in patients with schizophrenia in Taiwan. Prog. Neuropsychopharmacol. Biol. Psychiatry 29, 523–527.CrossRefGoogle Scholar

Hunt, C. E., Shannon, D. C. (1992) Sudden infant death syndrome and sleeping position. Pediatrics 90, 115–118.Google Scholar

Hussar, A. E. (1965) Coronary heart disease in chronic schizophrenic patients: a clinicopathologic study. Circulation 31, 919–929.CrossRefGoogle Scholar

Hussar, A. E. (1968) Peptic ulcer in long-term institutionalized schizophrenic patients. Psychosom. Med. 30, 374–377.CrossRefGoogle Scholar

Ingram, D. M., Nottage, E. M., Roberts, A. N. (1990) Prolactin and breast cancer risk. Med. J. Aust. 153, 469–473.Google Scholar

Inoue, H., Hazama, H., Ogura, C., Ichikawa, M., Tamura, T. (1980) Neuroendocrinological study of amenorrhea induced by antipsychotic drugs. Folia Psychiatr. Neurol. Jap. 34, 181.Google Scholar

Jablensky, A. V., Morgan, V., Zubrick, S. R., Bower, C., Yellachich, L. A. (2005) Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders. Am. J. Psychiatry 162, 79–91.CrossRefGoogle Scholar

Jakubaschk, J., Boker, W. (1991) [Disorders of pain perception in schizophrenia.]Schweiz. Arch. Neurol. Psychiatr. 142, 55–76.Google Scholar

Jara-Prado, A., Yescas, P., Sanchez, F. J.et al. (2000) Prevalence of acute intermittent porphyria in a Mexican psychiatric population. Arch. Med. Res. 31, 404–408.CrossRefGoogle Scholar

Jeste, D. V., Gladsjo, J. A., Lindamer, L. A., Lacro, J. P. (1996) Medical comorbidity in schizophrenia. Schizophr. Bull. 22, 413–430.CrossRefGoogle Scholar

Jeste, S. D., Patterson, T. L., Palmer, B. W.et al. (2003) Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia. Schizophr. Res. 63, 49–58.CrossRefGoogle Scholar

Jones, G. R. (1985) Cancer therapy: phenothiazines in an unexpected role. Tumori 71, 563–569.CrossRefGoogle Scholar

Jones, L. E., Clarke, W., Carney, C. P. (2004) Receipt of diabetes services by insured adults with and without claims for mental disorders. Med. Care 42, 1167–1175.CrossRefGoogle Scholar

Jose, C. J., Perez-Cruet, J. (1979) Incidence and morbidity of self-induced water intoxication in state mental hospital patients. Am. J. Psychiatry 136, 221–222.Google Scholar

Kaelbling, R., Craig, J. B., Pasamanick, B. (1961) Urinary porphobilinogen: results of screening 2500 psychiatric patients. Arch. Gen. Psychiatry 5, 494–508.CrossRefGoogle Scholar

Kales, A., Marusak, C. (1967) Sleep patterns associated with neurological and psychiatric disorders. Bull. Los Angeles Neurol. Soc. 32, 234–242.Google Scholar

Kalkan, A., Ozdarendeli, A., Bulut, Y.et al. (2005) Prevalence and genotypic distribution of hepatitis GB-C/HG and TT viruses in blood donors, mentally retarded children and four groups of patients in eastern Anatolia, Turkey. Jpn. J. Infect. Dis. 58, 222–227.Google Scholar

Kaplan, H. S., Sager, C. J., Schwartz, S., Kaye, A., Glass, G. B. (1970) Post-gastrectomy pain and schizophrenia. Psychosomatics 11, 157–163.CrossRefGoogle Scholar

Keely, E. J., Reiss, J. P., Drinkwater, D. T., Faiman, C. (1997) Bone mineral density, sex hormones, and long-term use of neuroleptic agents in men. Endocrinol. Pract. 3, 209–213.CrossRefGoogle Scholar

Kelly, C., McCreadie, R. G. (1999) Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland. Am. J. Psychiatry 156, 1751–1757.Google Scholar

Kenkre, A. M., Spadigam, A. E. (2000) Oral health and treatment needs in institutionalized psychiatric inpatients in India. Indian J. Dent. Res. 11, 5–11.Google Scholar

King, D. L., Cooper, S. J., Earle, J. A.et al. (1985) A survey of serum antibodies to eight common viruses in psychiatric patients. Br. J. Psychiatry 147, 137–144.CrossRefGoogle Scholar

Kirch, D. G., Bigelow, L. B., Weinberger, D. R., Lawson, W. B., Wyatt, R. J. (1985) Polydipsia and chronic hyponatremia in schizophrenic inpatients. J. Clin. Psychiatry 46, 179–181.Google Scholar

Kishimoto, T., Watanabe, K., Takeuchi, H.et al. (2005) Bone mineral density measurement in female inpatients with schizophrenia. Schizophr. Res. 77, 113–115.CrossRefGoogle Scholar

Kleinberg, D. L., Davis, J. M., Coster, R., Baelen, B., Brecher, M. (1999) Prolactin levels and adverse events in patients treated with risperidone. J. Clin. Psychopharmacol. 19, 57–61.CrossRefGoogle Scholar

Klibanski, A., Neer, R. M., Beitins, I. Z.et al. (1980) Decreased bone density in hyperprolactinemic women. N. Engl. J. Med. 303, 1511–1514.CrossRefGoogle Scholar

Kooy, F. H. (1919) Hyperglycemia in mental disorders. Brain 42, 214–288.CrossRefGoogle Scholar

Korhonen, S., Hippelainen, M., Niskanen, L., Vanhala, M., Saarikoski, S. (2001) Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study. Am. J. Obstet. Gynecol. 184, 289–296.CrossRefGoogle Scholar

Krakowski, A. J., Rydzynski, A., Jarosz, M., Engelsmann, F. (1983) Prevalence of psychosomatic disorders in schizophrenic patients in Poland. In Psychosomatic Medicine: Theoretical, Clinical and Transcultural Aspects, eds. Krakowski, A. J., Kimbal, R.. New York: Plenum Press, 69–78.CrossRef

Kroll, J. (2001) Schizophrenia and liver dysfunction. Med. Hypotheses 56, 634–636.CrossRefGoogle Scholar

Kunugi, H., Nanko, S., Murray, R. M. (2001) Obstetric complications and schizophrenia: prenatal underdevelopment and subsequent neurodevelopmental impairment. Br. J. Psychiatry (Suppl.) 40, S25–S29.CrossRefGoogle Scholar

Laaksonen, D. E., Lakka, H. M., Niskanen, L. K.et al. (2002) Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am. J. Epidemiol. 156, 1070–1077.CrossRefGoogle Scholar

Lambert, M. T., Bjarnason, I., Connelly, J.et al. (1989) Small intestine permeability in schizophrenia. Br. J. Psychiatry 155, 619–622.CrossRefGoogle Scholar

Lane, E. A., Albee, G. W. (1970) The birth weight of children born to schizophrenic women. J. Psychol. 74, 157–160.CrossRefGoogle Scholar

Lauerma, H., Lehtinen, V., Joukamaa, M.et al. (1998) Schizophrenia among patients treated for rheumatoid arthritis and appendicitis. Schizophr. Res. 29, 255–261.CrossRefGoogle Scholar

Lautenbacher, S., Krieg, J. C. (1994) Pain perception in psychiatric disorders: a review of the literature. J. Psychiatr. Res. 28, 109–122.CrossRefGoogle Scholar

Lawrence, D. M., Holman, C. D., Jablensky, A. V., Threlfall, T. J., Fuller, S. A. (2000) Excess cancer mortality in Western Australian psychiatric patients due to higher case fatality rates. Acta Psychiatr. Scand. 101, 382–388.CrossRefGoogle Scholar

Lawrence, D. M., Jablensky, A. V., Holman, C. D. J. (2001) Duty to Care: Physical Illness in People with Mental Illness. Available online at http://cdh.curtin.edu.au/publications/2001.cfm/

Lawrence, D. M., Holman, C. D., Jablensky, A. V., Hobbs, M. S. (2003) Death rate from ischaemic heart disease in Western Australian psychiatric patients 1980–1998. Br. J. Psychiatry 182, 31–36.CrossRefGoogle Scholar

Lee, H. K., Travin, S., Bluestone, H. (1992) human immunodeficiency virus-1 in inpatients. Hosp. Commun. Psychiatry 43, 181–182.Google Scholar

Leucht, S. M., Pitschel-Walz, G., Abraham, D., Kissling, W. (1999) Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo: a meta-analysis or randomized controlled trials. Schizophr. Res. 35, 51–68.CrossRefGoogle Scholar

Levine, J., Agam, G., Sela, B. A.et al. (2005a) cerebrospinal fluid homocysteine is not elevated in schizophrenia. J. Neur. Transm. 112, 297–302.

Levine, J., Sela, B. A., Osher, Y., Belmaker, R. H. (2005b) High homocysteine serum levels in young male schizophrenia and bipolar patients and in an animal model. Prog. Neuropsychopharmacol. Biol. Psychiatry 29, 1181–1191.

Levy, D. L., Holzman, P. S., Proctor, L. R. (1983) Vestibular dysfunction and psychopathology. Schizophr. Bull. 9, 383–438.CrossRefGoogle Scholar

Levy, R. P., Jensen, J. B., Laus, V. G., Agle, D. P., Engel, I. M. (1981) Serum thyroid hormone abnormalities in psychiatric disease. Metabolism 30, 1060–1064.CrossRefGoogle Scholar

Lewis, S., Jagger, R. G., Treasure, E. (2001) The oral health of psychiatric in-patients in South Wales. Spec. Care Dentist. 21, 182–186.CrossRefGoogle Scholar

Lichtermann, D., Ekelund, J., Pukkala, E., Tanskanen, A., Lonnqvist, J. (2001) Incidence of cancer among persons with schizophrenia and their relatives. Arch. Gen. Psychiatry 58, 573–578.CrossRefGoogle Scholar

Lieberman, A. L. (1955) Painless myocardial infarction in psychotic patients. Geriatrics 10, 579–580.CrossRefGoogle Scholar

Lin, C. C., Bai, Y. M., Chen, J. Y., Lin, C. Y., Lan, T. H. (1999) A retrospective study of clozapine and urinary incontinence in Chinese in-patients. Acta Psychiatr. Scand. 100, 158–161.CrossRefGoogle Scholar

Liu-Seifert, H., Kinon, B. J., Ahl, J., Lamberson, S. (2004) Osteopenia associated with increased prolactin and aging in psychiatric patients treated with prolactin-elevating antipsychotics. Ann. N. Y. Acad. Sci. 1032, 297–298.CrossRefGoogle Scholar

Llovera, M., Pichard, C., Bernichtein, S.et al. (2000) Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation. Oncogene 19, 4695–4705.CrossRef

Lovett Doust, J. W. (1980) Sinus tachycardia and abnormal cardiac rate variation in schizophrenia. Neuropsychobiology 6, 305–312.CrossRefGoogle Scholar

Lycke, E., Norrby, R., Roos, B. E. (1974) A serological study on mentally ill patients with particular reference to the prevalence of herpes virus infections. Br. J. Psychiatry 124, 273–279.CrossRefGoogle Scholar

Macdonald, S., Halliday, J., MacEwan, T.et al. (2003) Nithsdale Schizophrenia Surveys 24: sexual dysfunction – case-control study. Br. J. Psychiatry 182, 50–56.CrossRef

Magharious, W., Goff, D. C., Amico, E. (1998) Relationship of gender and menstrual status to symptoms and medication side effects in patients with schizophrenia. Psychiatr. Res. 77, 159–166.CrossRefGoogle Scholar

Marchand Walter, E. (1955) Occurrence of painless myocardial infarction in psychotic patients. N. Engl. J. Med. 253, 51–55.CrossRefGoogle Scholar

Marchand Walter, E., Sarota, B., Marble, H. C.et al. (1959) Occurrence of painless acute surgical disorders in psychotic patients. N. Engl. J. Med. 260, 580–585.

Marcus, J., Auerbach, J., Wilkinson, L., Burack, C. M. (1981) Infants at risk for schizophrenia: the Jerusalem Infant Development Study. Arch. Gen. Psychiatry 38, 703–713.CrossRefGoogle Scholar

Marder, S. R., Essock, S. M., Miller, A. L.et al. (2004) Physical health monitoring of patients with schizophrenia. Am. J. Psychiatry 161, 1334–1349.CrossRef

Martinez-Bermejo, A., Polanco, I. (2002) [Neuropsychological changes in coeliac disease.]Rev. Neurol. 34 (Suppl. 1), S24–S33.Google Scholar

Mason, P. R., Winton, F. E. (1995) Ear disease and schizophrenia: a case-control study. Acta Psychiatr. Scand. 91, 217–221.CrossRefGoogle Scholar

Masterson, E., O'Shea, B. (1984) Smoking and malignancy in schizophrenia. Br. J. Psychiatry 145, 429–432.CrossRefGoogle Scholar

Maudsley, H. (1979) The Pathology of Mind, 3rd end. London: Macmillan.

May, P. R. A. (1948) Pupillary abnormalities in schizophrenia and during muscular effort. J. Ment. Sci. 94, 89–98.CrossRefGoogle Scholar

McCreadie, R. G. (2003) Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study. Br. J. Psychiatry 183, 534–539.CrossRefGoogle Scholar

McCreadie, R. G., Stevens, H., Henderson, J.et al. (2004) The dental health of people with schizophrenia. Acta Psychiatr. Scand. 110, 306–310.CrossRef

McDermott, S., Moran, R., Platt, T.et al. (2005) Heart disease, schizophrenia, and affective psychoses: epidemiology of risk in primary care. Commun. Ment. Health J. 41, 747–755.CrossRef

McEvoy, J. P., Meyer, J. M., Goff, D. C.et al. (2005) Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (Clinical Trials of Antipsychotic Treatment Effectiveness) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr. Res. 80, 19–32.CrossRef

McGuffin, P., Gardiner, P., Swinburne, L. M. (1981) Schizophrenia, celiac disease, and antibodies to food. Biol. Psychiatry 16, 281–285.Google Scholar

McKee, H. A., D'Arcy, P. F., Wilson, P. J. (1986) Diabetes and schizophrenia: a preliminary study. J. Clin. Hosp. Pharm. 11, 297–299.CrossRefGoogle Scholar

McLarty, D. G., Ratcliffe, W. A., Ratcliffe, J. G., Shimmins, J. G., Goldberg, A. (1978) A study of thyroid function in psychiatric in-patients. Br. J. Psychiatry 133, 211–218.CrossRefGoogle Scholar

McNeil, T. F., Kaij, L. (1973) Obstetric complications and physical size of offspring of schizophrenic, schizophrenic-like, and control mothers. Br. J. Psychiatry 123, 341–348.Google Scholar

McNeil, T. F., Kaij, L., Malmquist-Larsson, A.et al. (1983) Offspring of women with nonorganic psychoses: development of a longitudinal study of children at high risk. Acta Psychiatr. Scand. 68, 234–250.CrossRef

Meaney, A. M., O'Keane, V. (2002) Prolactin and schizophrenia: clinical consequences of hyperprolactinaemia. Life Sci. 71, 979–992.CrossRefGoogle Scholar

Meaney, A. M., Smith, S., Howes, O. D.et al. (2004) Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia. Br. J. Psychiatry 184, 503–508.

Mednick, S. A., Mura, E., Schulsinger, F., Mednick, B. (1971) Perinatal conditions and infant development in children with schizophrenic parents. Soc. Biol. 18, S103–S113.Google Scholar

Mellsop, G. W., Koadlow, L., Syme, J., Whittingham, S. (1974) Absence of rheumatoid arthritis in schizophrenia. Aust. N. Z. J. Med. 4, 247–252.CrossRefGoogle Scholar

Meltzer, H. Y. (1976) Serum creatine phosphokinase in schizophrenia. Am. J. Psychiatry 133, 192–197.Google Scholar

Meltzer, H. Y., Davidson, M., Glassman, A. H., Vieweg, W. V. (2002) Assessing cardiovascular risks versus clinical benefits of atypical antipsychotic drug treatment. J. Clin. Psychiatry 63 (Suppl. 9), 25–29.Google Scholar

Mercier-Guidez, E., Loas, G. (2000) Polydipsia and water intoxication in 353 psychiatric inpatients: an epidemiological and psychopathological study. Eur. Psychiatry 15, 306–311.CrossRefGoogle Scholar

Meyer, J. M. (2003) Cardiovascular illness and hyperlipidemia in patients with schizophrenia. In Medical Illness and Schizophrenia, eds. Meyer, J. M., Nasrallah, H. A.. Washington, DC: American Psychiatric Publishing, pp. 53–80.

Meyer, J. M., Koro, C. E. (2004) The effects of antipsychotic therapy on serum lipids: a comprehensive review. Schizophr. Res. 70, 1–17.CrossRefGoogle Scholar

Meyer, J. M., Nasrallah, H. A. (eds.) (2003) Medical illness and schizophrenia. Washington, DC: American Psychiatric Publishing.

Meyer, I., McKinnon, K., Cournos, F.et al. (1993) (human immunodeficiency virus seroprevalence among long-stay patients in a state psychiatric hospital. Hosp. Commun. Psychiatry 44, 282–284.

Meyer, J. M., Koro, C. E., L'Italien, G. J. (2005) The metabolic syndrome and schizophrenia: a review. Int. Rev. Psychiatry 17, 173–180.CrossRefGoogle Scholar

Miller, L. J., Finnerty, M. (1996) Sexuality, pregnancy, and childrearing among women with schizophrenia-spectrum disorders. Psychiatr. Serv. 47, 502–506.Google Scholar

Millson, R. C., Smith, A. P., Koczapski, A. B.et al. (1993) Self-induced water intoxication treated with group psychotherapy. Am. J. Psychiatry 150, 825–826.

Mirdal, G. K., Mednick, S. A., Schulsinger, F., Fuchs, F. (1974) Perinatal complications in children of schizophrenic mothers. Acta Psychiatr. Scand. 50, 553–568.Google Scholar

Miyaoka, T., Seno, H., Itoga, M.et al. (2000) Schizophrenia-associated idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). J. Clin. Psychiatry 61, 868–871.CrossRef

Modrzewska, K. (1980) The offspring of schizophrenic parents in a North Swedish isolate. Clin. Genet. 17, 191–201.CrossRefGoogle Scholar

Mohamed, S. N., Merskey, H., Kazarian, S., Disney, T. F. (1982) An investigation of the possible inverse relationships between the occurrence of rheumatoid arthritis, osteoarthritis and schizophrenia. Can. J. Psychiatry 27, 381–383.CrossRefGoogle Scholar

Mokdad, A. H., Ford, E. S., Bowman, B. A.et al. (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. J. Am. Med. Assoc. 289, 76–79.CrossRef

Monti, J. M., Monti, D. (2004) Sleep in schizophrenia patients and the effects of antipsychotic drugs. Sleep Med. Rev. 8, 133–148.CrossRefGoogle Scholar

Morley, J. E., Shafer, R. B. (1982) Thyroid function screening in new psychiatric admissions. Arch. Intern. Med. 142, 591–593.CrossRefGoogle Scholar

Mors, O., Mortensen, P. B., Ewald, H. (1999) A population-based register study of the association between schizophrenia and rheumatoid arthritis. Schizophr. Res. 40, 67–74.CrossRefGoogle Scholar

Mortensen, P. B. (1987) Neuroleptic treatment and other factors modifying cancer risk in schizophrenic patients. Acta Psychiatr. Scand. 75, 585–590.CrossRefGoogle Scholar

Mortensen, P. B. (1989) The incidence of cancer in schizophrenic patients. J. Epidemiol. Commun. Health 43, 43–47.CrossRefGoogle Scholar

Mortensen, P. B. (1992) Neuroleptic medication and reduced risk of prostate cancer in schizophrenic patients. Acta Psychiatr. Scand. 85, 390–393.Google Scholar

Mortensen, P. B. (1994) The occurrence of cancer in first admitted schizophrenic patients. Schizophr. Res. 12, 185–194.CrossRefGoogle Scholar

Mukherjee, S., Decina, P., Bocola, V., Saraceni, F., Scapicchio, P. L. (1996) Diabetes mellitus in schizophrenic patients. Compr. Psychiatry 37, 68–73.CrossRefGoogle Scholar

Muller, N., Schiller, P., Ackenheil, M. (1991) Coincidence of schizophrenia and hyperbilirubinemia. Pharmacopsychiatry 24, 225–228.CrossRefGoogle Scholar

Munck-Jorgensen, P., Mors, O., Mortensen, P. B., Ewald, H. (2000) The schizophrenic patient in the somatic hospital. Acta Psychiatr. Scand. (Suppl.) 102, 96–99.Google Scholar

Muntjewerff, J. W., Blom, H. J. (2005) Aberrant folate status in schizophrenic patients: what is the evidence?Prog. Neuropsychopharmacol. Biol. Psychiatry 29, 1133–1139.CrossRefGoogle Scholar

Murphy, G. M.., Lim, K. O., Wieneke, M.et al. (1998) No neuropathologic evidence for an increased frequency of Alzheimer's disease among elderly schizophrenics. Biol. Psychiatry 43, 205–209.CrossRef

Naber, D., Pajonk, F. G., Perro, C., Lohmer, B. (1994) Human immunodeficiency virus antibody test and seroprevalence in psychiatric patients. Acta Psychiatr. Scand. 89, 358–361.CrossRefGoogle Scholar

Naidoo, U., Goff, D. C., Klibanski, A. (2003) Hyperprolactinemia and bone mineral density: the potential impact of antipsychotic agents. Psychoneuroendocrinology 28 (Suppl. 2), 97–108.CrossRefGoogle Scholar

Nakamura, Y., Koh, M., Miyoshi, E.et al. (2004) High prevalence of the hepatitis C virus infection among the inpatients of schizophrenia and psychoactive substance abuse in Japan. Prog. Neuropsychopharmacol. Biol. Psychiatry 28, 591–597.CrossRef

Nakane, Y., Ohta, Y. (1986) The example of linkage with a cancer register. In Psychiatric Case Registers in Public Health, eds. Horn, G. H. Ten, Giel, R., Gulbinat, W. H.. Amsterdam: Elsevier, pp. 240–245.

National Heart, Lung and Blood Institute (2001) Definition of Hypertension. Available online at www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&DB=pubmed

National Institutes of Health (2004) Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 27, 596–601.

Negulici, E., Christodorescu, D. (1967) Paranoid schizophrenia and Klinefelter's syndrome. Psychiatr. Neurol.(Basel) 154, 27–36.CrossRefGoogle Scholar

Neimeier, R., Hauser, G. A., Keller, M.et al. (1959) [Pathological lactation.]Schweiz. Med. Wochenschr. 89, 442–445.

Newcomer, J. W. (2005) Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. central nervous system Drugs 19 (Suppl. 1), 1–93.CrossRefGoogle Scholar

Newcomer, J. W., Haupt, D. W., Fucetola, R.et al. (2002) Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia. Arch. Gen. Psychiatry 59, 337–345.CrossRef

Newman, S. C., Bland, R. C. (1991) Mortality in a cohort of patients with schizophrenia: a record linkage study. Can. J. Psychiatry 36, 239–245.CrossRefGoogle Scholar

Nicholson, G., Liebling, L. I., Hall, R. A. (1976) Thyroid dysfunction in female psychiatric patients. Br. J. Psychiatry 129, 236–238.CrossRefGoogle Scholar

Nilsson, E., Lichtenstein, P., Cnattingius, S., Murray, R. M., Hultman, C. M. (2002) Women with schizophrenia: pregnancy outcome and infant death among their offspring. Schizophr. Res. 58, 221–229.CrossRefGoogle Scholar

Nissen, H. A., Spencer, K. A. (1936) The psychogenic problem (endocrinal and metabolic) in chronic arthritis. N. Engl. J. Med. 21, 567–581.Google Scholar

Nordenberg, J., Fenig, E., Landau, M., Weizman, R., Weizman, A. (1999) Effects of psychotropic drugs on cell proliferation and differentiation. Biochem. Pharmacol. 58, 1229–1236.CrossRefGoogle Scholar

Nyback, H., Wiesel, F. A., Berggren, B. M., Hindmarsh, T. (1982) Computed tomography of the brain in patients with acute psychosis and in healthy volunteers. Acta Psychiatr. Scand. 65, 403–414.CrossRefGoogle Scholar

O'Keane, V., Meaney, A. M. (2005) Antipsychotic drugs: a new risk factor for osteoporosis in young women with schizophrenia?J. Clin. Psychopharmacol. 25, 26–31.CrossRefGoogle Scholar

Ohta, Y., Nakane, Y., Mine, M.et al. (1988) The epidemiological study of physical morbidity in schizophrenics. 2. Association between schizophrenia and incidence of tuberculosis. Jpn. J. Psychiatry Neurol. 42, 41–47.Google Scholar

Oken, R. J., Schulzer, M. (1999) At issue: schizophrenia and rheumatoid arthritis – the negative association revisited. Schizophr. Bull. 25, 625–638.CrossRefGoogle Scholar

Okura, M., Morii, S. (1986) Polydipsia, polyuria and water intoxication observed in psychiatric inpatients. Tokushima J. Exp. Med. 33, 1–5.Google Scholar

Osborn, D. P., King, M. B., Nazareth, I. (2003) Participation in screening for cardiovascular risk by people with schizophrenia or similar mental illnesses: cross sectional study in general practice. Br. Med. J. 326, 1122–1123.CrossRefGoogle Scholar

Ostbye, T., Curtis, L. H., Masselink, L. E.et al. (2005) Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study. Pharmacoepidemiol. Drug Saf. 14, 407–415.Google Scholar

Osterberg, E. (1978) Schizophrenia and rheumatic disease: a study on the concurrence of inflammatory joint diseases and a review of 58 case-records. Acta Psychiatr. Scand. 58, 339–359.CrossRefGoogle Scholar

Osterlind, A. (1990) Malignant melanoma in Denmark: occurrence and risk factors. Acta Oncol. 29, 833–854.CrossRefGoogle Scholar

Othman, S. S., Abdul, K. K., Hassan, J.et al. (1994) High prevalence of thyroid function test abnormalities in chronic schizophrenia. Aust. N. Z. J. Psychiatry 28, 620–624.CrossRefGoogle Scholar

Oxenstierna, G., Bergstrand, G., Bjerkenstedt, L., Sedvall, G., Wik, G. (1984) Evidence of disturbed cerebrospinal fluid circulation and brain atrophy in cases of schizophrenic psychosis. Br. J. Psychiatry 144, 654–661.CrossRefGoogle Scholar

Paffenberger, R. S., Steinmetz, C. H., Pooler, B. G., Hyde, R. T. (1961) The picture puzzle of the postpartum psychosis. J. Chronic Dis. 13, 161–173.CrossRefGoogle Scholar

Palmer, B. A., Pankratz, V. S., Bostwick, J. M. (2005) The lifetime risk of suicide in schizophrenia: a re-examination. Arch. Gen. Psychiatry 62, 247–253.CrossRefGoogle Scholar

Paton, C., Esop, R., Young, C., Taylor, D. (2004) Obesity, dyslipidaemias and smoking in an inpatient population treated with antipsychotic drugs. Acta Psychiatr. Scand. 110, 299–305.CrossRefGoogle Scholar

Peh, L. H., Devan, G. S., Eu, P. W. (1990) Water intoxication in psychiatric patients in Singapore. Singapore Med. J. 31, 238–241.Google Scholar

Pelissolo, A. (1997) [Epidemiology of psychopathologic disorders in infectious diseases.]Encephale 23, (Spec. No. 5), 3–8.Google Scholar

Perisic, V. N., Lopicic, Z., Kokai, G. (1990) Celiac disease and schizophrenia: family occurrence. J. Pediatr. Gastroenterol. Nutr. 11, 279.CrossRefGoogle Scholar

Perkins, D. O. (2003) Prolactin- and endocrine-related disorders in schizophrenia. In Medical Illness and Schizophrenia, eds. Meyer, J. M., Nasrallah, H. A.. Washington, DC: American Psychiatric Publishing, pp. 215–232.

Pilkington, T. L. (1956) The coincidence of rheumatoid arthritis and schizophrenia. J. Nerv. Ment. Dis. 124, 604–606.CrossRefGoogle Scholar

Preti, A., Cardascia, L., Zen, T.et al. (2000) Risk for obstetric complications and schizophrenia. Psychiatr. Res. 96, 127–139.CrossRefGoogle Scholar

Primatesta, P., Hirani, V. (1999) Health Survey for England: The Health of Minority Ethnic Groups. 1999. London: Department of Health. http://www.official-documents.co.uk. 2007.

Prohovnik, I., Dwork, A. J., Kaufman, M. A.Willson, N. (1993) Alzheimer-type neuropathology in elderly schizophrenia patients. Schizophr. Bull. 19, 805–816.CrossRefGoogle Scholar

Pryce, I. G., Edwards, H. (1966) Persistent oral dyskinesia in female mental hospital patients. Br. J. Psychiatry 112, 983–987.CrossRefGoogle Scholar

Py, O., Mathieu, P. (1960) [Galactorrhea and disorders of the menstrual cycle in the course of neuroleptic treatments.]Presse Med. 68, 765–766.Google Scholar

Qin, P., Xu, H., Laursen, T. M., Vestergaard, M., Mortensen, P. B. (2005) Risk for schizophrenia and schizophrenia-like psychosis among patients with epilepsy: population-based cohort study. Br. Med. J. 331, 23.CrossRefGoogle Scholar

Ragins, N., Schachter, J., Elmer, E.et al. (1975) Infants and children at risk for schizophrenia: environmental and developmental observations. J. Am. Acad. Child Psychiatry 14, 150–177.CrossRefGoogle Scholar

Ramsay, R. A., Ananth, J., Engelsmann, F.et al. (1982) Schizophrenia and psychosomatic illness. J. Psychosom. Res. 26, 33–42.CrossRefGoogle Scholar

Ravichand, D. M., Sheshayamma, V., Lakshmi Kameshwari, V., Chakradhar, T. (2005) Thyroid hormones and antithyroid drugs. Calicut Med. J. 3, e3.Google Scholar

Ray, W. A., Meredith, S., Thapa, P. B.et al. (2001) Antipsychotics and the risk of sudden cardiac death. Arch. Gen. Psychiatry 58, 1161–1167.CrossRefGoogle Scholar

Regenold, W. T., Thapar, R. K., Marano, C., Gavirneni, S., Kondapavuluru, P. V. (2002) Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. J. Affect. Disord. 70, 19–26.CrossRefGoogle Scholar

Reilly, J. G., Ayis, S. A., Ferrier, I. N., Jones, S. J., Thomas, S. H. (2000) QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet 355, 1048–1052.CrossRefGoogle Scholar

Rieder, R. O., Rosenthal, D., Wender, P., Blumenthal, H. (1975) The offspring of schizophrenics. 1. Fetal and neonatal deaths. Arch. Gen. Psychiatry 32, 200–211.CrossRefGoogle Scholar

Rieder, R. O., Broman, S. H., Rosenthal, D. (1977) The offspring of schizophrenics. 2. Perinatal factors and IQ. Arch. Gen. Psychiatry 34, 789–799.Google Scholar

Riggs, A. T., Dysken, M. W., Kim, S. W., Opsahl, J. A. (1991) A review of disorders of water homeostasis in psychiatric patients. Psychosomatics 32, 133–148.CrossRefGoogle Scholar

Rimon, R., Halonen, P., Puhakka, P.et al. (1979) Immunoglobulin G antibodies to herpes simplex type 1 virus detected by radioimmunoassay in serum and cerebrospinal fluid of patients with schizophrenia. J. Clin. Psychiatry 40, 241–243.Google Scholar

Riscalla, L. M. (1980) Blindness and schizophrenia. Med. Hypotheses 6, 1327–1328.CrossRefGoogle Scholar

Robins, A. H. (1972) Phenothiazine melanosis in schizophrenic patients. Psychopharmacologia 27, 327–342.CrossRefGoogle Scholar

Roca, R. P., Blackman, M. R., Ackerley, M. B., Harman, S. M., Gregerman, R. I. (1990) Thyroid hormone elevations during acute psychiatric illness: relationship to severity and distinction from hyperthyroidism. Endocr. Res. 16, 415–447.CrossRefGoogle Scholar

Rodgers-Johnson, P. E., Hickling, F. W., Irons, A.et al. (1996) Retroviruses and schizophrenia in Jamaica. Mol. Chem. Neuropathol. 28, 237–243.Google Scholar

Rose, D. P., Pruitt, B. T. (1981) Plasma prolactin levels in patients with breast cancer. Cancer 48, 2687–2691.Google Scholar

Rosenberg, S. D., Goodman, L. A., Osher, F. C.et al.(2001) Prevalence of human immunodeficiency virus, hepatitis B, and hepatitis C in people with severe mental illness. Am. J. Public Health 91, 31–37.Google Scholar